ArticleAfrican journal of primary health care & family medicine2026
Cardiometabolic risk profile and associated factors among adults with type 2 diabetes in a primary health care clinics in North Central Nigeria.
Article in African journal of primary health care & family medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiometabolic abnormalities substantially increase morbidity among individuals with type 2 diabetes mellitus (T2DM), particularly in primary health care (PHC) settings. In Nigeria, evidence on comprehensive metabolic risk profiling beyond glycaemic control remains limited.
aimTo determine the cardiometabolic risk profile and identify factors associated with adverse cardiometabolic outcomes among adults with T2DM.
settingThe study took place at government-owned PHC facilities in Makurdi, Benue State, Nigeria.
methodsThis facility-based analytical cross-sectional study systematically recruited 120 eligible adults aged ≥ 30 years with T2DM. Socio-demographic and clinical data were obtained using structured questionnaires and medical records. Laboratory analyses assessed glycaemic status, lipid profile and renal function. Renal impairment was determined using estimated glomerular filtration rate (eGFR) based on standard clinical thresholds. Cardiometabolic abnormality was defined as the presence of at least one abnormal component: poor glycaemic control, dyslipidaemia or renal impairment. Data were analysed using descriptive statistics and logistic regression.
resultsThe mean age was 56 ± 10.8 years, with females comprising 61.7%. The mean diabetes duration was 4 ± 3.2 years. Overall, 84.8% had at least one cardiometabolic abnormality. Poor glycaemic control, dyslipidaemia and renal impairment occurred in 65.8%, 65.0% and 29.2%, respectively. The mean cardiometabolic risk score was 1.87 ± 1.05. Longer diabetes duration independently predicted poor glycaemic control (p 0.05).
conclusionAdults with T2DM attending PHC clinic had a high burden of cardiometabolic abnormalities, highlighting the need for integrated diabetes management strategies.Contribution: The study provides context-specific evidence to support routine lipid and renal function assessment in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.